The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Accumulation of metformin by tissues of the normal and diabetic mouse
Abstract
1. Tissue accumulation of the antihyperglycaemic agent metformin (dimethylbiguanide) was examined after oral administration to the normal and streptozotocin (STZ) diabetic mouse. 2. Metformin (50 mg/kg body weight containing 14C-metformin 25 microCi/kg body weight), which is stable and not metabolized, resulted in maximum plasma concentrations at 0.5 h which declined to < 5% of maximum by 24 h. Maximum plasma concentrations (mumol/l, mean +/- SE) in the hepatic portal vein (normal 51.7 +/- 5.4, STZ 61.5 +/- 8.0) were higher than in the inferior vena cava (normal 29.0 +/- 2.8, STZ 35.4 +/- 5.9). 3. The greatest accumulation of metformin occurred in tissues of the small intestine, where maximum concentrations were > 1000 mumol/kg wet weight at 0.5-2 h, but declined to < 2% of maximum by 24 h. 4. Stomach, colon, salivary gland, kidney and liver accumulated metformin more than two-fold, and concentrations of the drug in heart and skeletal (gastrocnemius) muscle were greater than plasma concentrations on some occasions up to 8 h. 5. In a separate study, i.v.-administered metformin was selectively accumulated by tissues of the small intestine. Thus, retention of metformin by tissues of the small intestine may represent a deep compartment for the drug.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In both studies, Arunachalam et al. (110) and Ghosh et al. (111) used 50 μM metformin and justified this concentration on the basis that estimates of metformin levels in the portal circulation following oral absorption are between 40 and 70 μM (4, 181).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [181]
Citations
Cites
Singh, B. N., Ellrodt, G. A., & Peter, C. T. (1978) · Drugs · doi:10.2165/00003495-197815030-00001 · Cited by 835
Bailey, C. J. (1992) · Diabetes Care · doi:10.2337/diacare.15.6.755 · Cited by 593
Self-citationMetformin kinetics in healthy subjects and in patients with diabetes mellitus.
Tucker, G., Casey, C., Phillips, P., Connor, H., Ward, J. D., & Woods, H. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01206.x · Cited by 503
Pharmacokinetics of Metformin After Intravenous and Oral Administration to Man
Pentik�inen, P. J., Neuvonen, P. J., & Penttil�, A. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562061 · Cited by 348
Disposition of metformin (N,N‐dimethylbiguanide) in man
Sirtori, C. R., Franceschini, G., Galli-Kienle, M., Cighetti, G., Galli, G., Bondioli, A., & Conti, F. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978246683 · Cited by 222
Metformin: a review of its pharmacological properties and therapeutic use.
Ls, H. (1979) · PubMed · Cited by 175
Determination of glucose by an automatic analyser
Stevens, J. F. (1971) · Clinica Chimica Acta · doi:10.1016/0009-8981(71)90332-9 · Cited by 166
Konturek, S. J. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-789_4 · Cited by 158
Effect of metformin on glucose metabolism in the splanchnic bed
Bailey, C. J., Wilcock, C., & Day, C. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09093.x · Cited by 131
Self-citationMetformin in the digestive tract
Vidon, N., Chaussade, S., Noël, M., Franchisseur, C., Huchet, B., & Bernier, J. J. (1988) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(88)80022-6 · Cited by 117
Research works printed but not linked: 7
- Bailey C. J., 1988, Balliere's Clinical Endocrinology and Metabolism, 2, 455
- Bailey C. J., 1986, Diabete et Metabolisme, 12, 212
- Cigolini M., 1984, Diabete et Metabolisme, 10, 311
- Cohen P. Y., 1961, Therapie, 16, 109
- Hermann L. S, 1979, Diabete et Metabolisme, 5, 233
- Mordes J. P., 1985, Joslin's Diabetes Mellitus12th edn, 110
- Noel M, 1979, Research and Clinical Forums, 1, 35
Cited by
Sorted by citations
Items 401–414 of 414
Zannella, V. E., Pra, A. D., Muaddi, H., McKee, T. D., Stapleton, S., Sykes, J. R., Glicksman, R., Chaib, S., Zamiara, P., Milosevic, M., et al. (2023) · doi:10.1158/1078-0432.c.6521136.v1
Potential Role of Metformin in Central Nervous System with a Focus on Its Mechanism of Actions
Bora, K., & James, R. (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i04.4279 · Cited by 1
Inoue, Y., Niimi, A., Kudo, T., Yoshizaki, U., Sato, Y., & Kume, H. (2025) · IJU Case Reports · doi:10.1002/iju5.70055
Metformin Boosts Intestinal Lipid sensing via GIP to Suppress Feeding
Kuah, R., Wang, M. T., Yang, Z., Back, G., Li, R. J. W., Bruce, K., LoChoy, J. N., Beaudry, J. L., Barros, D. R., Zhang, S., et al. (2025) · doi:10.2337/figshare.29458850
Additional file 1 of Metformin alters therapeutic effects in the BALB/c tumor therapy model
Meyer, F. B., Goebel, S., Spangel, S. B., Leovsky, C., Hoelzer, D., & Thierbach, R. (2021) · Figshare · doi:10.6084/m9.figshare.14691850
Additional file 2 of Metformin alters therapeutic effects in the BALB/c tumor therapy model
Meyer, F. B., Goebel, S., Spangel, S. B., Leovsky, C., Hoelzer, D., & Thierbach, R. (2021) · Figshare · doi:10.6084/m9.figshare.14691853
Rouquet, T. (2015) · theses.fr (ABES) · doi:10.70675/680971a6z149ez4296z9c76z5ee9dfd53ce5
Metformin & Chronic Kidney Disease (CKD) : a reassessment of the benefit/risk ratio
Kajbaf, F. (2015) · theses.fr (ABES) · doi:10.70675/7a26b581z94ddz4e2fz9a48z97f6f7d8354a
Rôle des adipocytokines dans l'obésité, l'insulino-résistance et leurs conséquences sur la fertilité
Bongrani, A. (2022) · theses.fr (ABES) · doi:10.70675/1b281dcdz1f16z4985z95f8z0706a492c996
The coordinated actions of metformin in the intestine and liver improves hyperglycemia
He, L., An, H., Ramirez, K., Radovick, S., & Wondisford, F. E. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117791 · Cited by 1
Oral delivery of metformin: unravelling the role of intestinal transporters
Haydon, L. A., Šitovs, A., & Mohylyuk, V. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108856
Zhang, K., Chen, Y., Ran, L., Tong, W., Dai, L., Yang, Z., Chen, Q., Zheng, J., & Hu, G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1857676
Wang, G., Zhao, Y., Liu, G., Du, Y., Liu, S., Yang, Y., Bu, S., & Zhao, B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198451
Metadata
- Authors
- Wilcock, C., & Bailey, C. J.
- Affiliations
- Aston University (GB)
- ORCID
- Bailey, C. J.
- Venue
- Xenobiotica
- Publisher
- Informa UK Limited
- Published
- 1994-01
- Volume
- 24
- Issue
- 1
- Pages
- 49-57
- ISSN
- 0049-8254 (ISSN-L)
- 1366-5928
- OpenAlex
- W2136667764
- Cited by
- 418
- References
- 23
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 20 · 2023: 23 · 2022: 22 · 2021: 23 · 2020: 21 · 2019: 24 · 2018: 30 · 2017: 31 · 2016: 26 · 2015: 31 · 2014: 30 · 2013: 19 · 2012: 12
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Xenobiotica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, tissue accumulation, streptozotocin-induced diabetes, small intestine, drug retention, plasma concentration, oral administration, antidiabetic drugs, drug distribution
- MeSH terms
- Administration, Oral, Animals, Diabetes Mellitus, Experimental, Digestive System, Injections, Intravenous, Male, Metformin, Mice, Inbred Strains, Tissue Distribution, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review